Citi Pharma 1QFY27 profit rises 22% to Rs249m
Loading...
Consolidated profit for the period of Citi Pharma Limited (PSX: CPHL) rose 22.14% year-on-year to Rs248.79m for the quarter ended September 30, 2026, compared with Rs203.69m in the same period last year.
Go to articleAdal Fintech moves closer to PSX listing
Zuma Resources plans Rs350m SPAC to target AI
Cherat Cement to acquire 64.07% stake in Nimir Chemical
NBP issues foreign exchange rates
Oil prices retreat to $110 on Iran diplomacy hopes
Asian markets tumble amid tech sell-off, AI spending concerns
Pakistan assumes G-24 chairmanship
MG Morning Breeze: Updates to Skim before Market
Petrol price freeze costs refiners PKR49/litre
Must-Reads\Don't Miss
No Easy Exit : A Refund is not an Exoneration
Half a point, and a longer road to target
MPC Preview: Oil bites. Will SBP bite back?
Pakistan as an Emerging Power in Global Minerals
SE Fruits IPO: The CTIs Said All Was Well. So What Went Wrong?
Khaadi’s IPO: The brand you know, the numbers you should know
| Name | Price/Vol | %Chg/NChg |
|---|
| Symbol | Bid/Ask | High/Low |
|---|
| Name | Last | High/Low | Chg/%Chg |
|---|
Chart of the Day
Top 5 things to watch in this week
MTB Auction Numbers That Matter
Pakistan Stock Movers
| Name | Last | Chg/%Chg |
|---|
| Name | Last | Chg/%Chg |
|---|